2017-03-17,How to Trade the Week's Most Active Stocks--Rite Aid, Amgen, MuleSoft and More
2017-03-17,The Medicines Company And Alnylam Pharmaceuticals Report Positive Final Results From ORION-1 Phase II Study Of Inclisiran
2017-03-17,AveXis, Esperion and Amgen Among Biotech Movers
2017-03-14,The Medicines Company To Webcast Presentation Of ORION-1 Phase II Study Of Inclisiran At ACC.17
2017-03-06,The Medicines Company To Host Conference Call And Webcast At Upcoming American College Of Cardiology's 66th Annual Scientific Sessions
2017-02-28,The Medicines Company Reports Fourth-Quarter And Full-Year 2016 Financial Results
2017-02-21,The Medicines Company Announces FDA Filing Acceptance Of New Drug Application For Intravenous Antibiotic Carbavance® (meropenem-vaborbactam)
2017-02-17,The Medicines Company To Announce Fourth-Quarter And Full-Year 2016 Financial Results On February 28, 2017
2017-02-15,Biotech Premarket Movers: Ardelyx, Acorda Therapeutics, Medicines Co.
2017-02-03,Insiders Seeing Green With MDCO At New 52-Week High
2017-02-03,Premarket Biotech Movers: Portola, Esperion, Medicines
2017-01-25,The Medicines Company To Present Results From ORION-1 Phase 2 Study Of Inclisiran At The American College Of Cardiology's 66th Annual Scientific Session
2017-01-08,The Medicines Company Announces Positive Top-Line Results From Day 180 Interim Analysis In Ongoing ORION-1 Phase 2 Study Of Inclisiran (formerly, PCSK9si)
2017-01-06,Amgen Shares Skyrocket on Surprise Patent Victory, Plus Jim Cramer's View
2017-01-04,The Medicines Company To Present At J. P. Morgan Healthcare Conference
2016-12-15,5 Stocks Insiders Love Right Now
2016-11-15,The Medicines Company And Alnylam Pharmaceuticals Present Positive Results From ORION-1 Phase 2 Study Of Inclisiran (formerly PCSK9si)
2016-11-13,Http://www.themedicinescompany.com/
2016-11-10,The Medicines Company To Host Conference Call And Webcast To Review Data From Ongoing ORION-1 Phase 2 Study Of PCSK9si
2016-11-07,The Medicines Company Discontinues Development Of MDCO-216, Its Investigational Cholesterol Efflux Promoter
2016-10-26,The Medicines Company Reports Third-Quarter 2016 Financial Results
2016-10-18,The Medicines Company Announces Positive Top-Line Results From Day 90 Interim Analysis In Ongoing ORION-1 Phase 2 Study Of PCSK9si
2016-10-17,The Medicines Company To Announce Third Quarter Financial Results On October 26, 2016
2016-10-17,The Medicines Company's Infectious Disease Portfolio Featured In 16 Presentations At IDWeek 2016
2016-10-13,The Medicines Company To Present Data From Its Investigational Anesthetic MDCO-700 At The ANESTHESIOLOGY® 2016 Annual Meeting And The ISAP 25th Annual Meeting
2016-10-06,Why Medicines Co. (MDCO) Stock is Falling Today
2016-10-05,The Medicines Company Provides Progress Update On Ongoing ORION-1 Study Of PCSK9si
2016-10-05,Notable Wednesday Option Activity: MDCO, PEIX, BEAT
2016-09-21,The Medicines Company Awarded Up To $132 Million To Develop Portfolio Of New Antibiotics Targeting Drug-Resistant Infections Under Strategic Partnership With BARDA
2016-08-30,The Medicines Company Provides Update On Dyslipidemia Programs
2016-07-27,The Medicines Company Reports Second-Quarter 2016 Business And Financial Results
2016-07-18,The Medicines Company To Announce Second Quarter Financial Results On July 27, 2016
2016-07-12,Federal Circuit Rules For The Medicines Company In Angiomax® (bivalirudin) Patent Litigation
2016-07-11,Barbarian At The Gate: Medicines (MDCO)
2016-06-27,Medicines (MDCO) Flagged As Strong On High Volume
2016-06-27,The Medicines Company Announces Positive Top- Line Results For Phase 3 TANGO 1 Clinical Trial Of CARBAVANCE®
2016-06-21,The Medicines Company Completes Divestiture Of Its Non-Core Cardiovascular Assets To Chiesi
2016-06-15,Insiders Are Scooping Up Shares of These 5 Stocks
2016-06-14,The Medicines Company Announces Initiation Of Phase II Study For Its Investigational Anesthetic, ABP-700
2016-06-13,The Medicines Company Announces Participation At ASM MICROBE 2016 To Be Held June 16 - 20 In Boston
2016-06-09,MDCO: Insiders vs. Shorts
2016-06-07,Medicines (MDCO) Moving On Heavy Pre-Market Trading
2016-06-06,The Medicines Company Prices $350 Million Of Convertible Notes
2016-06-06,Barbarian At The Gate: Medicines (MDCO)
2016-06-06,The Medicines Company Announces Intention To Offer $350 Million Of Convertible Notes
2016-06-02,The Medicines Company Completes Patient Enrollment For ORION-1 Study Of PCSK9si
2016-05-26,The Medicines Company Announces Completion Of Patient Enrollment In Phase 3 TANGO 1 Study Of CARBAVANCE® (meropenem-vaborbactam) For Treatment Of Complicated Urinary Tract Infections (cUTI)
2016-05-25,The Medicines Company To Present At Two Upcoming Investor Conferences
2016-05-18,5 Stocks Insiders Are Scooping Up Right Now
2016-05-16,The Medicines Company Appoints Tony Kingsley As President And Chief Operating Officer
2016-05-09,The Medicines Company Reports First-Quarter 2016 Business And Financial Results
2016-05-09,The Medicines Company Agrees To Divest Non-Core Cardiovascular Assets To Chiesi Farmaceutici S.p.A.
2016-05-02,The Medicines Company To Present At Bank Of America Merrill Lynch 2016 Health Care Conference
2016-04-26,The Medicines Company To Announce First Quarter Financial Results On May 9, 2016
2016-04-11,FDA Grants Fast Track Status For Investigational Antibiotic CARBAVANCE® (meropenem-vaborbactam)
2016-04-04,The Medicines Company Announces Participation At 2016 European Congress Of Clinical Microbiology And Infectious Diseases (ECCMID) To Be Held April 9-12 In Amsterdam
2016-03-28,The Medicines Company Announces Participation At 2016 American College Of Cardiology (ACC) Scientific Sessions In Chicago
2016-03-09,Insider Trading Alert - MDCO, DXCM And WMGI Traded By Insiders
2016-03-02,The Medicines Company To Present At Cowen And Company 36th Annual Health Care Conference
2016-02-19,The Medicines Company To Participate In 2016 RBC Capital Markets Global Healthcare Conference
2016-02-18,Medicines (MDCO) Stock Price Target Lowered at Jefferies
2016-02-17,Medicines Co. (MDCO) Stock Jumping on Q4 Results
2016-02-17,The Medicines Company Reports Fourth-Quarter And Full-Year 2015 Business And Financial Results
2016-02-05,Clive Meanwell, MD, PhD Receives Dr. Sol J. Barer Award At BioNJ Gala Event
2016-02-04,The Medicines Company To Announce Fourth Quarter And Full Year 2015 Financial Results On Wednesday, February 17, 2016
2016-02-03,The Medicines Company Appoints Alexander J. Denner, Ph.D. To Its Board Of Directors
2016-02-02,The Medicines Company To Participate In Leerink Partners 5th Annual Global Healthcare Conference
2016-02-01,The Medicines Company Completes Divestiture Of Its Hemostasis Portfolio To Mallinckrodt Plc
2016-01-21,Medicines (MDCO) Highlighted As Today's Perilous Reversal Stock
2016-01-20,Why Medicines (MDCO) Stock is Advancing Today
2016-01-20,Strong On High Volume: Medicines (MDCO)
2016-01-11,The Medicines Company Advances Clinical Development Of Investigational First-in-Class PCSK9 Synthesis Inhibitor For Atherosclerotic Cardiovascular Disease (ASCVD)
2016-01-04,Medicines (MDCO) Stock: Weak On High Volume Today
2016-01-04,The Medicines Company To Participate In J.P. Morgan 34th Annual Healthcare Conference
2015-12-22,Today's Dead Cat Bounce Stock Is Medicines (MDCO)
2015-12-18,Mallinckrodt Diversifies Hospital Growth Portfolio, Acquiring Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
2015-12-18,The Medicines Company Agrees To Divest Its Hemostasis Portfolio To Mallinckrodt Plc
2015-12-14,The Medicines Company Announces Investigational Lipid Modulating Agent, MDCO-216, Phase 1 Data Published In European Heart Journal- Cardiovascular Pharmacotherapy
2015-12-09,Glenn Sblendorio To Retire As President And Chief Financial Officer From The Medicines Company
2015-12-04,The Medicines Company To Participate In Oppenheimer 26th Annual Healthcare Conference
2015-11-20,The Medicines Company Receives European Commission Approval For IONSYS® 40 Micrograms Per Dose Transdermal System (fentanyl) To Treat Post-Operative Pain In Adult Hospitalized Patients
2015-11-13,Federal Circuit Overturns District Court Decision On Angiomax Patents; Grants The Medicines Company's Request For Rehearing Of Appeal
2015-11-13,Medicines Company (MDCO) Marked As A Barbarian At The Gate
2015-11-11,Alnylam Pharmaceuticals And The Medicines Company Announce That New ALN-PCSsc Results From Late-Breaking Presentation At American Heart Association Meeting Confirm Potential For Bi-Annual Hypercholesterolemia Dose Regimen
2015-11-04,The Medicines Company To Present New Data On Cardiovascular Portfolio At American Heart Association (AHA) Scientific Sessions
2015-11-03,Medicines Company (MDCO) Flagged As Strong On High Volume
2015-11-03,The Medicines Company Reports Third-Quarter And First Nine Months 2015 Business And Financial Results
2015-10-26,Results Of First-in-Man Study With Investigational Anesthetic ABP-700 Presented At ANESTHESIOLOGY® 2015 And International Society Of Anesthetic Pharmacology Annual Meetings
2015-10-22,The Medicines Company To Present Data On Potentially Innovative Surgical Anesthetic At American Society Of Anesthesiologists 2015 Meeting
2015-10-16,The Medicines Company To Announce Third Quarter 2015 Financial Results On Tuesday, November 3, 2015
2015-10-06,The Medicines Company And SymBio Pharmaceuticals Establish Strategic Partnership For IONSYS® (fentanyl Iontophoretic Transdermal System) In Japan
2015-10-01,The Medicines Company Announces Participation At IDWeek 2015 Meeting
2015-10-01,The Medicines Company Announces BARDA Exercises Next Option On Contract For Support Of The Development Of CARBAVANCE® (meropenem/RPX7009) For Drug-Resistant Gram-Negative Pathogens
2015-09-30,10 Best Nasdaq Biotech Stocks in the Third Quarter
2015-09-28,Short Interest Makes 17.2% Move For MDCO
2015-09-25,First Week Of November 20th Options Trading For Medicines
2015-09-25,The Medicines Company Receives CHMP Positive Opinion For IONSYS® To Treat Post-operative Pain In Adult Patients
2015-09-18,Trade-Ideas: Medicines Company (MDCO) Is Today's Post-Market Leader Stock
2015-09-18,The Medicines Company Reports Discovery Of New Series Of Beta-Lactamase Inhibitors At ICAAC/ICC 2015
2015-09-18,New Treatment Options For Carbapenem-Resistant Enterobacteriaceae (CRE) Infection Needed, According To Study By The Medicines Company
2015-09-15,The Medicines Company Announces Participation At ICAAC/ICC 2015 Meeting
2015-09-09,Medicines Company (MDCO) Hits New Lifetime High Today
2015-09-09,EUSA Pharma Appoints William W Crouse To Its Board Of Directors
2015-09-01,MATRIX Trial Results Presented At Hot Line Session Of ESC Congress 2015 And Simultaneously Published In The New England Journal Of Medicine
2015-09-01,Medicines Company (MDCO) Reaches New Lifetime High Today
2015-09-01,Analysis From CHAMPION PHOENIX Trial Highlight The Efficacy Of Cangrelor Among Patients Undergoing PCI Via The Radial Approach
2015-08-31,Market News: The Medicine Company, Netflix, Twitter
2015-08-31,3 High-Volume Stocks to Trade Now (or Not)
2015-08-31,3 Health Care Stocks Nudging The Sector Higher
2015-08-31,Medicines (MDCO) Stock Skyrockets Following Promising Cholesterol Drug Results
2015-08-31,Medicines Company (MDCO) Moving On Heavy Volume In The Pre-Market Hours
2015-08-31,The Medicines Company Appoints Dr. Fred Eshelman As Non-Executive Chairman Of The Board
2015-08-30,(Graphic: Business Wire)
2015-08-28,Analysts' Actions -- Akamai, Borg Warner, Urban Outfitters, United States Steel and More
2015-08-24,The Medicines Company Announces Participation At 2015 European Society Of Cardiology (ESC) Congress In London
2015-08-19,The Medicines Co. (MDCO) Stock Price Target Raised at Leerink
2015-07-29,Today's Weak On High Volume Stock: Medicines Company (MDCO)
2015-07-29,The Medicines Company Reports Second-Quarter And First-Half 2015 Financial Results
2015-07-13,The Medicines Company To Announce Second Quarter Financial Results On Wednesday July 29, 2015
2015-07-09,The Medicines Company Authorizes Generic Launch Of ANGIOMAX® (bivalirudin)
2015-07-07,4 Stocks Rising on Unusual Volume
2015-07-06,Strong On High Relative Volume: Medicines Company (MDCO)
2015-07-02,Will Medicines & Co. (MDCO) Stock be Hurt by Court Patent Ruling?
2015-07-02,Federal Circuit Rules Against The Medicines Company In Angiomax® (bivalirudin) Patent Litigation
2015-06-25,Medicines Company (MDCO) Marked As A Barbarian At The Gate
2015-06-22,KENGREAL(TM)(cangrelor)(Photo: Business Wire)
2015-06-11,Insider Trading Alert - CLCT, MDCO And LQ Traded By Insiders
2015-06-01,The Medicines Company To Hold Conference Call On Tuesday, June 2 To Discuss Clinical Trial Results Of ABP-700 And MDCO-216
2015-06-01,Bios/Backgrounders
2015-05-26,The Medicines Company Presents New Data Showing Remodeling Effect Of MDCO-216 On HDL Particles In Coronary Artery Disease Patients
2015-05-22,The Medicines Company To Participate In The Jefferies 2015 Healthcare Conference
2015-05-19,First Week Of January 2016 Options Trading For Medicines (MDCO)
2015-05-07,The Medicines Company To Participate In Bank Of America Merrill Lynch 2015 Health Care Conference
2015-05-05,The Medicines Company Reports First Quarter 2015 Financial Results And Operational Developments
2015-04-30,The Medicines Company Announces FDA Approval Of RAPLIXA™ (Fibrin Sealant), The First And Only Powdered Fibrin Sealant Ready-to-Use For Mild To Moderate Surgical Bleeding
2015-04-30,The Medicines Company Announces FDA Approval Of IONSYS® (fentanyl Iontophoretic Transdermal System) For The Management Of Acute Post-Operative Pain For Adult Patients In The Hospital
2015-04-21,Insider Trading Alert - AMP, MDCO And MEMP Traded By Insiders
2015-04-21,The Medicines Company To Announce First Quarter Financial Results On Tuesday, May 5, 2015
2015-04-20,Medicines Company (MDCO) Weak On High Volume
2015-04-20,FDA Approves New Formulation Of MINOCIN® (minocycline) For Injection
2015-04-15,FDA Advisory Committee Recommends Approval Of The Medicines Company's Antiplatelet Therapy Cangrelor
2015-04-15,The Medicines Company Stock Trading Halted Today
2015-04-13,Medicines Company (MDCO) Strong On High Relative Volume Today
2015-04-10,Medicines Company (MDCO) Moving On Heavy Volume In The Pre-Market Hours
2015-04-09,EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against The Medicines Company - MDCO
2015-04-09,The Medicines Company Announces Preliminary Worldwide Net Revenue For The First Quarter Of 2015
2015-04-01,The Medicines Company Settles Angiomax® (Bivalirudin) Patent Litigation With Sun
2015-03-30,The Medicines Company Receives European Commission Approval For Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV® (oritavancin) And RAPLIXA™ (sealant Powder)
2015-03-19,Insider Trading Alert - MDCO, NMIH And LNG Traded By Insiders
2015-03-16,Independent Research Confirms Reduction In Mortality And Bleeding Associated With Bivalirudin In High-Risk Acute Coronary Syndrome Patients Undergoing PCI
2015-03-11,The Medicines Company Announces Participation At 2015 American College Of Cardiology (ACC) Scientific Sessions In San Diego
2015-02-27,The Medicines Company To Participate In Cowen 35th Annual Health Care Conference
2015-02-20,The Medicines Company To Participate In 2015 RBC Capital Markets' Global Healthcare Conference
2015-02-18,The Medicines Company Reports Fourth Quarter And Full Year 2014 Financial Results
2015-02-12,Interesting MDCO Put And Call Options For March 20th
2015-02-12,Short Interest In Medicines Expands By 16.5%
2015-02-05,The Medicines Company To Participate In Leerink Global Healthcare Conference
2015-02-04,The Medicines Company Acquires Annovation Biopharma, Inc.
2015-02-04,The Medicines Company To Announce Fourth Quarter And Full Year 2014 Financial Results On Wednesday, February 18, 2015
2015-01-23,The Medicines Company Receives CHMP Positive Opinions For Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV™ (oritavancin) And RAPLIXA™ (sealant Powder)
2015-01-21,Eyes On Medicines Company (MDCO): Highlighted Storm The Castle Stock
2015-01-07,The Medicines Company Prices $350 Million Of Convertible Notes
2015-01-06,The Medicines Company Announces Intention To Offer $300 Million Of Convertible Notes
2015-01-05,The Medicines Company To Participate In 33rd Annual J.P. Morgan Healthcare Conference
2014-12-31,Weak On High Volume: Medicines Company (MDCO)
2014-12-24,Commit To Purchase Medicines At $21, Earn 11.9% Annualized Using Options
2014-12-18,The Medicines Company And SciClone Pharmaceuticals Establish Strategic Partnership For Two Cardiovascular Products In China
2014-12-11,Http://www.themedicinescompany.com/
2014-12-08,The Medicines Company To Participate In Oppenheimer 25th Annual Healthcare Conference
2014-11-16,The Medicines Company Presents New Phase 1 Data Showing Investigational Agent MDCO-216 Modified Key Lipid Parameters And Was Well-Tolerated In Healthy And Coronary Artery Disease (CAD) Patients
2014-11-14,The Medicines Company To Present New Data On Investigational Lipid-Modifying Agent MDCO-216 And Investigational Antiplatelet Agent Cangrelor At 2014 American Heart Association (AHA) Annual Scientific Sessions In Chicago
2014-11-11,The Medicines Company To Participate In Credit Suisse Healthcare Conference
2014-11-07,Health Economic Data On The Medicines Company's Infectious Disease And Cardiology Portfolios To Be Presented At The 17th Annual European Congress Of The International Society For Pharmacoeconomics And Outcomes Research (ISPOR)
2014-11-05,The Medicines Company Announces First Patient Enrollment In Phase 3 Studies Of CARBAVANCE™ In Development For The Treatment Of Serious Bacterial Infections Due To Gram-Negative Bacteria
2014-11-04,Update To The Medicines Company Investor & Analyst Day On November 5
2014-10-30,The Medicines Company To Webcast Investor & Analyst Day On November 5
2014-10-28,Twitter Takes A Tumble As Ability To Innovate Comes Into Question
2014-10-28,The Medicines Company Announces Presentation Of Investigational Hemostatic Agent RAPLIXA™ (fibrin Sealant) Phase III FINISH-3 Trial Results At The 2014 Clinical Conference Of The American College Of Surgeons
2014-10-28,Alnylam And The Medicines Company Announce Filing Of A Clinical Trial Application To Initiate A Phase 1 Study For ALN-PCSsc, An Investigational, Subcutaneously Administered RNAi Therapeutic Targeting PCSK9 For The Treatment Of Hypercholesterolemia
2014-10-27,The Medicines Company Wins Favorable Judgment In Angiomax® (Bivalirudin) Patent Litigation
2017-03-17,How to Trade the Week's Most Active Stocks--Rite Aid, Amgen, MuleSoft and More
2017-03-17,The Medicines Company And Alnylam Pharmaceuticals Report Positive Final Results From ORION-1 Phase II Study Of Inclisiran
2017-03-17,AveXis, Esperion and Amgen Among Biotech Movers
2017-03-14,The Medicines Company To Webcast Presentation Of ORION-1 Phase II Study Of Inclisiran At ACC.17
2017-03-06,The Medicines Company To Host Conference Call And Webcast At Upcoming American College Of Cardiology's 66th Annual Scientific Sessions
2017-02-28,The Medicines Company Reports Fourth-Quarter And Full-Year 2016 Financial Results
2017-02-21,The Medicines Company Announces FDA Filing Acceptance Of New Drug Application For Intravenous Antibiotic Carbavance® (meropenem-vaborbactam)
2017-02-17,The Medicines Company To Announce Fourth-Quarter And Full-Year 2016 Financial Results On February 28, 2017
2017-02-15,Biotech Premarket Movers: Ardelyx, Acorda Therapeutics, Medicines Co.
2017-02-03,Insiders Seeing Green With MDCO At New 52-Week High
2017-02-03,Premarket Biotech Movers: Portola, Esperion, Medicines
2017-01-25,The Medicines Company To Present Results From ORION-1 Phase 2 Study Of Inclisiran At The American College Of Cardiology's 66th Annual Scientific Session
2017-01-08,The Medicines Company Announces Positive Top-Line Results From Day 180 Interim Analysis In Ongoing ORION-1 Phase 2 Study Of Inclisiran (formerly, PCSK9si)
2017-01-06,Amgen Shares Skyrocket on Surprise Patent Victory, Plus Jim Cramer's View
2017-01-04,The Medicines Company To Present At J. P. Morgan Healthcare Conference
2016-12-15,5 Stocks Insiders Love Right Now
2016-11-15,The Medicines Company And Alnylam Pharmaceuticals Present Positive Results From ORION-1 Phase 2 Study Of Inclisiran (formerly PCSK9si)
2016-11-13,Http://www.themedicinescompany.com/
2016-11-10,The Medicines Company To Host Conference Call And Webcast To Review Data From Ongoing ORION-1 Phase 2 Study Of PCSK9si
2016-11-07,The Medicines Company Discontinues Development Of MDCO-216, Its Investigational Cholesterol Efflux Promoter
2016-10-26,The Medicines Company Reports Third-Quarter 2016 Financial Results
2016-10-18,The Medicines Company Announces Positive Top-Line Results From Day 90 Interim Analysis In Ongoing ORION-1 Phase 2 Study Of PCSK9si
2016-10-17,The Medicines Company To Announce Third Quarter Financial Results On October 26, 2016
2016-10-17,The Medicines Company's Infectious Disease Portfolio Featured In 16 Presentations At IDWeek 2016
2016-10-13,The Medicines Company To Present Data From Its Investigational Anesthetic MDCO-700 At The ANESTHESIOLOGY® 2016 Annual Meeting And The ISAP 25th Annual Meeting
2016-10-06,Why Medicines Co. (MDCO) Stock is Falling Today
2016-10-05,The Medicines Company Provides Progress Update On Ongoing ORION-1 Study Of PCSK9si
2016-10-05,Notable Wednesday Option Activity: MDCO, PEIX, BEAT
2016-09-21,The Medicines Company Awarded Up To $132 Million To Develop Portfolio Of New Antibiotics Targeting Drug-Resistant Infections Under Strategic Partnership With BARDA
2016-08-30,The Medicines Company Provides Update On Dyslipidemia Programs
2016-07-27,The Medicines Company Reports Second-Quarter 2016 Business And Financial Results
2016-07-18,The Medicines Company To Announce Second Quarter Financial Results On July 27, 2016
2016-07-12,Federal Circuit Rules For The Medicines Company In Angiomax® (bivalirudin) Patent Litigation
2016-07-11,Barbarian At The Gate: Medicines (MDCO)
2016-06-27,Medicines (MDCO) Flagged As Strong On High Volume
2016-06-27,The Medicines Company Announces Positive Top- Line Results For Phase 3 TANGO 1 Clinical Trial Of CARBAVANCE®
2016-06-21,The Medicines Company Completes Divestiture Of Its Non-Core Cardiovascular Assets To Chiesi
2016-06-15,Insiders Are Scooping Up Shares of These 5 Stocks
2016-06-14,The Medicines Company Announces Initiation Of Phase II Study For Its Investigational Anesthetic, ABP-700
2016-06-13,The Medicines Company Announces Participation At ASM MICROBE 2016 To Be Held June 16 - 20 In Boston
2016-06-09,MDCO: Insiders vs. Shorts
2016-06-07,Medicines (MDCO) Moving On Heavy Pre-Market Trading
2016-06-06,The Medicines Company Prices $350 Million Of Convertible Notes
2016-06-06,Barbarian At The Gate: Medicines (MDCO)
2016-06-06,The Medicines Company Announces Intention To Offer $350 Million Of Convertible Notes
2016-06-02,The Medicines Company Completes Patient Enrollment For ORION-1 Study Of PCSK9si
2016-05-26,The Medicines Company Announces Completion Of Patient Enrollment In Phase 3 TANGO 1 Study Of CARBAVANCE® (meropenem-vaborbactam) For Treatment Of Complicated Urinary Tract Infections (cUTI)
2016-05-25,The Medicines Company To Present At Two Upcoming Investor Conferences
2016-05-18,5 Stocks Insiders Are Scooping Up Right Now
2016-05-16,The Medicines Company Appoints Tony Kingsley As President And Chief Operating Officer
2016-05-09,The Medicines Company Reports First-Quarter 2016 Business And Financial Results
2016-05-09,The Medicines Company Agrees To Divest Non-Core Cardiovascular Assets To Chiesi Farmaceutici S.p.A.
2016-05-02,The Medicines Company To Present At Bank Of America Merrill Lynch 2016 Health Care Conference
2016-04-26,The Medicines Company To Announce First Quarter Financial Results On May 9, 2016
2016-04-11,FDA Grants Fast Track Status For Investigational Antibiotic CARBAVANCE® (meropenem-vaborbactam)
2016-04-04,The Medicines Company Announces Participation At 2016 European Congress Of Clinical Microbiology And Infectious Diseases (ECCMID) To Be Held April 9-12 In Amsterdam
2016-03-28,The Medicines Company Announces Participation At 2016 American College Of Cardiology (ACC) Scientific Sessions In Chicago
2016-03-09,Insider Trading Alert - MDCO, DXCM And WMGI Traded By Insiders
2016-03-02,The Medicines Company To Present At Cowen And Company 36th Annual Health Care Conference
2016-02-19,The Medicines Company To Participate In 2016 RBC Capital Markets Global Healthcare Conference
2016-02-18,Medicines (MDCO) Stock Price Target Lowered at Jefferies
2016-02-17,Medicines Co. (MDCO) Stock Jumping on Q4 Results
2016-02-17,The Medicines Company Reports Fourth-Quarter And Full-Year 2015 Business And Financial Results
2016-02-05,Clive Meanwell, MD, PhD Receives Dr. Sol J. Barer Award At BioNJ Gala Event
2016-02-04,The Medicines Company To Announce Fourth Quarter And Full Year 2015 Financial Results On Wednesday, February 17, 2016
2016-02-03,The Medicines Company Appoints Alexander J. Denner, Ph.D. To Its Board Of Directors
2016-02-02,The Medicines Company To Participate In Leerink Partners 5th Annual Global Healthcare Conference
2016-02-01,The Medicines Company Completes Divestiture Of Its Hemostasis Portfolio To Mallinckrodt Plc
2016-01-21,Medicines (MDCO) Highlighted As Today's Perilous Reversal Stock
2016-01-20,Why Medicines (MDCO) Stock is Advancing Today
2016-01-20,Strong On High Volume: Medicines (MDCO)
2016-01-11,The Medicines Company Advances Clinical Development Of Investigational First-in-Class PCSK9 Synthesis Inhibitor For Atherosclerotic Cardiovascular Disease (ASCVD)
2016-01-04,Medicines (MDCO) Stock: Weak On High Volume Today
2016-01-04,The Medicines Company To Participate In J.P. Morgan 34th Annual Healthcare Conference
2015-12-22,Today's Dead Cat Bounce Stock Is Medicines (MDCO)
2015-12-18,Mallinckrodt Diversifies Hospital Growth Portfolio, Acquiring Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
2015-12-18,The Medicines Company Agrees To Divest Its Hemostasis Portfolio To Mallinckrodt Plc
2015-12-14,The Medicines Company Announces Investigational Lipid Modulating Agent, MDCO-216, Phase 1 Data Published In European Heart Journal- Cardiovascular Pharmacotherapy
2015-12-09,Glenn Sblendorio To Retire As President And Chief Financial Officer From The Medicines Company
2015-12-04,The Medicines Company To Participate In Oppenheimer 26th Annual Healthcare Conference
2015-11-20,The Medicines Company Receives European Commission Approval For IONSYS® 40 Micrograms Per Dose Transdermal System (fentanyl) To Treat Post-Operative Pain In Adult Hospitalized Patients
2015-11-13,Federal Circuit Overturns District Court Decision On Angiomax Patents; Grants The Medicines Company's Request For Rehearing Of Appeal
2015-11-13,Medicines Company (MDCO) Marked As A Barbarian At The Gate
2015-11-11,Alnylam Pharmaceuticals And The Medicines Company Announce That New ALN-PCSsc Results From Late-Breaking Presentation At American Heart Association Meeting Confirm Potential For Bi-Annual Hypercholesterolemia Dose Regimen
2015-11-04,The Medicines Company To Present New Data On Cardiovascular Portfolio At American Heart Association (AHA) Scientific Sessions
2015-11-03,Medicines Company (MDCO) Flagged As Strong On High Volume
2015-11-03,The Medicines Company Reports Third-Quarter And First Nine Months 2015 Business And Financial Results
2015-10-26,Results Of First-in-Man Study With Investigational Anesthetic ABP-700 Presented At ANESTHESIOLOGY® 2015 And International Society Of Anesthetic Pharmacology Annual Meetings
2015-10-22,The Medicines Company To Present Data On Potentially Innovative Surgical Anesthetic At American Society Of Anesthesiologists 2015 Meeting
2015-10-16,The Medicines Company To Announce Third Quarter 2015 Financial Results On Tuesday, November 3, 2015
2015-10-06,The Medicines Company And SymBio Pharmaceuticals Establish Strategic Partnership For IONSYS® (fentanyl Iontophoretic Transdermal System) In Japan
2015-10-01,The Medicines Company Announces Participation At IDWeek 2015 Meeting
2015-10-01,The Medicines Company Announces BARDA Exercises Next Option On Contract For Support Of The Development Of CARBAVANCE® (meropenem/RPX7009) For Drug-Resistant Gram-Negative Pathogens
2015-09-30,10 Best Nasdaq Biotech Stocks in the Third Quarter
2015-09-28,Short Interest Makes 17.2% Move For MDCO
2015-09-25,First Week Of November 20th Options Trading For Medicines
2015-09-25,The Medicines Company Receives CHMP Positive Opinion For IONSYS® To Treat Post-operative Pain In Adult Patients
2015-09-18,Trade-Ideas: Medicines Company (MDCO) Is Today's Post-Market Leader Stock
2015-09-18,The Medicines Company Reports Discovery Of New Series Of Beta-Lactamase Inhibitors At ICAAC/ICC 2015
2015-09-18,New Treatment Options For Carbapenem-Resistant Enterobacteriaceae (CRE) Infection Needed, According To Study By The Medicines Company
2015-09-15,The Medicines Company Announces Participation At ICAAC/ICC 2015 Meeting
2015-09-09,Medicines Company (MDCO) Hits New Lifetime High Today
2015-09-09,EUSA Pharma Appoints William W Crouse To Its Board Of Directors
2015-09-01,MATRIX Trial Results Presented At Hot Line Session Of ESC Congress 2015 And Simultaneously Published In The New England Journal Of Medicine
2015-09-01,Medicines Company (MDCO) Reaches New Lifetime High Today
2015-09-01,Analysis From CHAMPION PHOENIX Trial Highlight The Efficacy Of Cangrelor Among Patients Undergoing PCI Via The Radial Approach
2015-08-31,Market News: The Medicine Company, Netflix, Twitter
2015-08-31,3 High-Volume Stocks to Trade Now (or Not)
2015-08-31,3 Health Care Stocks Nudging The Sector Higher
2015-08-31,Medicines (MDCO) Stock Skyrockets Following Promising Cholesterol Drug Results
2015-08-31,Medicines Company (MDCO) Moving On Heavy Volume In The Pre-Market Hours
2015-08-31,The Medicines Company Appoints Dr. Fred Eshelman As Non-Executive Chairman Of The Board
2015-08-30,(Graphic: Business Wire)
2015-08-28,Analysts' Actions -- Akamai, Borg Warner, Urban Outfitters, United States Steel and More
2015-08-24,The Medicines Company Announces Participation At 2015 European Society Of Cardiology (ESC) Congress In London
2015-08-19,The Medicines Co. (MDCO) Stock Price Target Raised at Leerink
2015-07-29,Today's Weak On High Volume Stock: Medicines Company (MDCO)
2015-07-29,The Medicines Company Reports Second-Quarter And First-Half 2015 Financial Results
2015-07-13,The Medicines Company To Announce Second Quarter Financial Results On Wednesday July 29, 2015
2015-07-09,The Medicines Company Authorizes Generic Launch Of ANGIOMAX® (bivalirudin)
2015-07-07,4 Stocks Rising on Unusual Volume
2015-07-06,Strong On High Relative Volume: Medicines Company (MDCO)
2015-07-02,Will Medicines & Co. (MDCO) Stock be Hurt by Court Patent Ruling?
2015-07-02,Federal Circuit Rules Against The Medicines Company In Angiomax® (bivalirudin) Patent Litigation
2015-06-25,Medicines Company (MDCO) Marked As A Barbarian At The Gate
2015-06-22,KENGREAL(TM)(cangrelor)(Photo: Business Wire)
2015-06-11,Insider Trading Alert - CLCT, MDCO And LQ Traded By Insiders
2015-06-01,The Medicines Company To Hold Conference Call On Tuesday, June 2 To Discuss Clinical Trial Results Of ABP-700 And MDCO-216
2015-06-01,Bios/Backgrounders
2015-05-26,The Medicines Company Presents New Data Showing Remodeling Effect Of MDCO-216 On HDL Particles In Coronary Artery Disease Patients
2015-05-22,The Medicines Company To Participate In The Jefferies 2015 Healthcare Conference
2015-05-19,First Week Of January 2016 Options Trading For Medicines (MDCO)
2015-05-07,The Medicines Company To Participate In Bank Of America Merrill Lynch 2015 Health Care Conference
2015-05-05,The Medicines Company Reports First Quarter 2015 Financial Results And Operational Developments
2015-04-30,The Medicines Company Announces FDA Approval Of RAPLIXA™ (Fibrin Sealant), The First And Only Powdered Fibrin Sealant Ready-to-Use For Mild To Moderate Surgical Bleeding
2015-04-30,The Medicines Company Announces FDA Approval Of IONSYS® (fentanyl Iontophoretic Transdermal System) For The Management Of Acute Post-Operative Pain For Adult Patients In The Hospital
2015-04-21,Insider Trading Alert - AMP, MDCO And MEMP Traded By Insiders
2015-04-21,The Medicines Company To Announce First Quarter Financial Results On Tuesday, May 5, 2015
2015-04-20,Medicines Company (MDCO) Weak On High Volume
2015-04-20,FDA Approves New Formulation Of MINOCIN® (minocycline) For Injection
2015-04-15,FDA Advisory Committee Recommends Approval Of The Medicines Company's Antiplatelet Therapy Cangrelor
2015-04-15,The Medicines Company Stock Trading Halted Today
2015-04-13,Medicines Company (MDCO) Strong On High Relative Volume Today
2015-04-10,Medicines Company (MDCO) Moving On Heavy Volume In The Pre-Market Hours
2015-04-09,EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against The Medicines Company - MDCO
2015-04-09,The Medicines Company Announces Preliminary Worldwide Net Revenue For The First Quarter Of 2015
2015-04-01,The Medicines Company Settles Angiomax® (Bivalirudin) Patent Litigation With Sun
2015-03-30,The Medicines Company Receives European Commission Approval For Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV® (oritavancin) And RAPLIXA™ (sealant Powder)
2015-03-19,Insider Trading Alert - MDCO, NMIH And LNG Traded By Insiders
2015-03-16,Independent Research Confirms Reduction In Mortality And Bleeding Associated With Bivalirudin In High-Risk Acute Coronary Syndrome Patients Undergoing PCI
2015-03-11,The Medicines Company Announces Participation At 2015 American College Of Cardiology (ACC) Scientific Sessions In San Diego
2015-02-27,The Medicines Company To Participate In Cowen 35th Annual Health Care Conference
2015-02-20,The Medicines Company To Participate In 2015 RBC Capital Markets' Global Healthcare Conference
2015-02-18,The Medicines Company Reports Fourth Quarter And Full Year 2014 Financial Results
2015-02-12,Interesting MDCO Put And Call Options For March 20th
2015-02-12,Short Interest In Medicines Expands By 16.5%
2015-02-05,The Medicines Company To Participate In Leerink Global Healthcare Conference
2015-02-04,The Medicines Company Acquires Annovation Biopharma, Inc.
2015-02-04,The Medicines Company To Announce Fourth Quarter And Full Year 2014 Financial Results On Wednesday, February 18, 2015
2015-01-23,The Medicines Company Receives CHMP Positive Opinions For Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV™ (oritavancin) And RAPLIXA™ (sealant Powder)
2015-01-21,Eyes On Medicines Company (MDCO): Highlighted Storm The Castle Stock
2015-01-07,The Medicines Company Prices $350 Million Of Convertible Notes
2015-01-06,The Medicines Company Announces Intention To Offer $300 Million Of Convertible Notes
2015-01-05,The Medicines Company To Participate In 33rd Annual J.P. Morgan Healthcare Conference
2014-12-31,Weak On High Volume: Medicines Company (MDCO)
2014-12-24,Commit To Purchase Medicines At $21, Earn 11.9% Annualized Using Options
2014-12-18,The Medicines Company And SciClone Pharmaceuticals Establish Strategic Partnership For Two Cardiovascular Products In China
2014-12-11,Http://www.themedicinescompany.com/
2014-12-08,The Medicines Company To Participate In Oppenheimer 25th Annual Healthcare Conference
2014-11-16,The Medicines Company Presents New Phase 1 Data Showing Investigational Agent MDCO-216 Modified Key Lipid Parameters And Was Well-Tolerated In Healthy And Coronary Artery Disease (CAD) Patients
2014-11-14,The Medicines Company To Present New Data On Investigational Lipid-Modifying Agent MDCO-216 And Investigational Antiplatelet Agent Cangrelor At 2014 American Heart Association (AHA) Annual Scientific Sessions In Chicago
2014-11-11,The Medicines Company To Participate In Credit Suisse Healthcare Conference
2014-11-07,Health Economic Data On The Medicines Company's Infectious Disease And Cardiology Portfolios To Be Presented At The 17th Annual European Congress Of The International Society For Pharmacoeconomics And Outcomes Research (ISPOR)
2014-11-05,The Medicines Company Announces First Patient Enrollment In Phase 3 Studies Of CARBAVANCE™ In Development For The Treatment Of Serious Bacterial Infections Due To Gram-Negative Bacteria
2014-11-04,Update To The Medicines Company Investor & Analyst Day On November 5
2014-10-30,The Medicines Company To Webcast Investor & Analyst Day On November 5
2014-10-28,Twitter Takes A Tumble As Ability To Innovate Comes Into Question
2014-10-28,The Medicines Company Announces Presentation Of Investigational Hemostatic Agent RAPLIXA™ (fibrin Sealant) Phase III FINISH-3 Trial Results At The 2014 Clinical Conference Of The American College Of Surgeons
2014-10-28,Alnylam And The Medicines Company Announce Filing Of A Clinical Trial Application To Initiate A Phase 1 Study For ALN-PCSsc, An Investigational, Subcutaneously Administered RNAi Therapeutic Targeting PCSK9 For The Treatment Of Hypercholesterolemia
2014-10-27,The Medicines Company Wins Favorable Judgment In Angiomax® (Bivalirudin) Patent Litigation
2017-03-17,How to Trade the Week's Most Active Stocks--Rite Aid, Amgen, MuleSoft and More
2017-03-17,The Medicines Company And Alnylam Pharmaceuticals Report Positive Final Results From ORION-1 Phase II Study Of Inclisiran
2017-03-17,AveXis, Esperion and Amgen Among Biotech Movers
2017-03-14,The Medicines Company To Webcast Presentation Of ORION-1 Phase II Study Of Inclisiran At ACC.17
2017-03-06,The Medicines Company To Host Conference Call And Webcast At Upcoming American College Of Cardiology's 66th Annual Scientific Sessions
2017-02-28,The Medicines Company Reports Fourth-Quarter And Full-Year 2016 Financial Results
2017-02-21,The Medicines Company Announces FDA Filing Acceptance Of New Drug Application For Intravenous Antibiotic Carbavance® (meropenem-vaborbactam)
2017-02-17,The Medicines Company To Announce Fourth-Quarter And Full-Year 2016 Financial Results On February 28, 2017
2017-02-15,Biotech Premarket Movers: Ardelyx, Acorda Therapeutics, Medicines Co.
2017-02-03,Insiders Seeing Green With MDCO At New 52-Week High
2017-02-03,Premarket Biotech Movers: Portola, Esperion, Medicines
2017-01-25,The Medicines Company To Present Results From ORION-1 Phase 2 Study Of Inclisiran At The American College Of Cardiology's 66th Annual Scientific Session
2017-01-08,The Medicines Company Announces Positive Top-Line Results From Day 180 Interim Analysis In Ongoing ORION-1 Phase 2 Study Of Inclisiran (formerly, PCSK9si)
2017-01-06,Amgen Shares Skyrocket on Surprise Patent Victory, Plus Jim Cramer's View
2017-01-04,The Medicines Company To Present At J. P. Morgan Healthcare Conference
2016-12-15,5 Stocks Insiders Love Right Now
2016-11-15,The Medicines Company And Alnylam Pharmaceuticals Present Positive Results From ORION-1 Phase 2 Study Of Inclisiran (formerly PCSK9si)
2016-11-13,Http://www.themedicinescompany.com/
2016-11-10,The Medicines Company To Host Conference Call And Webcast To Review Data From Ongoing ORION-1 Phase 2 Study Of PCSK9si
2016-11-07,The Medicines Company Discontinues Development Of MDCO-216, Its Investigational Cholesterol Efflux Promoter
2016-10-26,The Medicines Company Reports Third-Quarter 2016 Financial Results
2016-10-18,The Medicines Company Announces Positive Top-Line Results From Day 90 Interim Analysis In Ongoing ORION-1 Phase 2 Study Of PCSK9si
2016-10-17,The Medicines Company To Announce Third Quarter Financial Results On October 26, 2016
2016-10-17,The Medicines Company's Infectious Disease Portfolio Featured In 16 Presentations At IDWeek 2016
2016-10-13,The Medicines Company To Present Data From Its Investigational Anesthetic MDCO-700 At The ANESTHESIOLOGY® 2016 Annual Meeting And The ISAP 25th Annual Meeting
2016-10-06,Why Medicines Co. (MDCO) Stock is Falling Today
2016-10-05,The Medicines Company Provides Progress Update On Ongoing ORION-1 Study Of PCSK9si
2016-10-05,Notable Wednesday Option Activity: MDCO, PEIX, BEAT
2016-09-21,The Medicines Company Awarded Up To $132 Million To Develop Portfolio Of New Antibiotics Targeting Drug-Resistant Infections Under Strategic Partnership With BARDA
2016-08-30,The Medicines Company Provides Update On Dyslipidemia Programs
2016-07-27,The Medicines Company Reports Second-Quarter 2016 Business And Financial Results
2016-07-18,The Medicines Company To Announce Second Quarter Financial Results On July 27, 2016
2016-07-12,Federal Circuit Rules For The Medicines Company In Angiomax® (bivalirudin) Patent Litigation
2016-07-11,Barbarian At The Gate: Medicines (MDCO)
2016-06-27,Medicines (MDCO) Flagged As Strong On High Volume
2016-06-27,The Medicines Company Announces Positive Top- Line Results For Phase 3 TANGO 1 Clinical Trial Of CARBAVANCE®
2016-06-21,The Medicines Company Completes Divestiture Of Its Non-Core Cardiovascular Assets To Chiesi
2016-06-15,Insiders Are Scooping Up Shares of These 5 Stocks
2016-06-14,The Medicines Company Announces Initiation Of Phase II Study For Its Investigational Anesthetic, ABP-700
2016-06-13,The Medicines Company Announces Participation At ASM MICROBE 2016 To Be Held June 16 - 20 In Boston
2016-06-09,MDCO: Insiders vs. Shorts
2016-06-07,Medicines (MDCO) Moving On Heavy Pre-Market Trading
2016-06-06,The Medicines Company Prices $350 Million Of Convertible Notes
2016-06-06,Barbarian At The Gate: Medicines (MDCO)
2016-06-06,The Medicines Company Announces Intention To Offer $350 Million Of Convertible Notes
2016-06-02,The Medicines Company Completes Patient Enrollment For ORION-1 Study Of PCSK9si
2016-05-26,The Medicines Company Announces Completion Of Patient Enrollment In Phase 3 TANGO 1 Study Of CARBAVANCE® (meropenem-vaborbactam) For Treatment Of Complicated Urinary Tract Infections (cUTI)
2016-05-25,The Medicines Company To Present At Two Upcoming Investor Conferences
2016-05-18,5 Stocks Insiders Are Scooping Up Right Now
2016-05-16,The Medicines Company Appoints Tony Kingsley As President And Chief Operating Officer
2016-05-09,The Medicines Company Reports First-Quarter 2016 Business And Financial Results
2016-05-09,The Medicines Company Agrees To Divest Non-Core Cardiovascular Assets To Chiesi Farmaceutici S.p.A.
2016-05-02,The Medicines Company To Present At Bank Of America Merrill Lynch 2016 Health Care Conference
2016-04-26,The Medicines Company To Announce First Quarter Financial Results On May 9, 2016
2016-04-11,FDA Grants Fast Track Status For Investigational Antibiotic CARBAVANCE® (meropenem-vaborbactam)
2016-04-04,The Medicines Company Announces Participation At 2016 European Congress Of Clinical Microbiology And Infectious Diseases (ECCMID) To Be Held April 9-12 In Amsterdam
2016-03-28,The Medicines Company Announces Participation At 2016 American College Of Cardiology (ACC) Scientific Sessions In Chicago
2016-03-09,Insider Trading Alert - MDCO, DXCM And WMGI Traded By Insiders
2016-03-02,The Medicines Company To Present At Cowen And Company 36th Annual Health Care Conference
2016-02-19,The Medicines Company To Participate In 2016 RBC Capital Markets Global Healthcare Conference
2016-02-18,Medicines (MDCO) Stock Price Target Lowered at Jefferies
2016-02-17,Medicines Co. (MDCO) Stock Jumping on Q4 Results
2016-02-17,The Medicines Company Reports Fourth-Quarter And Full-Year 2015 Business And Financial Results
2016-02-05,Clive Meanwell, MD, PhD Receives Dr. Sol J. Barer Award At BioNJ Gala Event
2016-02-04,The Medicines Company To Announce Fourth Quarter And Full Year 2015 Financial Results On Wednesday, February 17, 2016
2016-02-03,The Medicines Company Appoints Alexander J. Denner, Ph.D. To Its Board Of Directors
2016-02-02,The Medicines Company To Participate In Leerink Partners 5th Annual Global Healthcare Conference
2016-02-01,The Medicines Company Completes Divestiture Of Its Hemostasis Portfolio To Mallinckrodt Plc
2016-01-21,Medicines (MDCO) Highlighted As Today's Perilous Reversal Stock
2016-01-20,Why Medicines (MDCO) Stock is Advancing Today
2016-01-20,Strong On High Volume: Medicines (MDCO)
2016-01-11,The Medicines Company Advances Clinical Development Of Investigational First-in-Class PCSK9 Synthesis Inhibitor For Atherosclerotic Cardiovascular Disease (ASCVD)
2016-01-04,Medicines (MDCO) Stock: Weak On High Volume Today
2016-01-04,The Medicines Company To Participate In J.P. Morgan 34th Annual Healthcare Conference
2015-12-22,Today's Dead Cat Bounce Stock Is Medicines (MDCO)
2015-12-18,Mallinckrodt Diversifies Hospital Growth Portfolio, Acquiring Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
2015-12-18,The Medicines Company Agrees To Divest Its Hemostasis Portfolio To Mallinckrodt Plc
2015-12-14,The Medicines Company Announces Investigational Lipid Modulating Agent, MDCO-216, Phase 1 Data Published In European Heart Journal- Cardiovascular Pharmacotherapy
2015-12-09,Glenn Sblendorio To Retire As President And Chief Financial Officer From The Medicines Company
2015-12-04,The Medicines Company To Participate In Oppenheimer 26th Annual Healthcare Conference
2015-11-20,The Medicines Company Receives European Commission Approval For IONSYS® 40 Micrograms Per Dose Transdermal System (fentanyl) To Treat Post-Operative Pain In Adult Hospitalized Patients
2015-11-13,Federal Circuit Overturns District Court Decision On Angiomax Patents; Grants The Medicines Company's Request For Rehearing Of Appeal
2015-11-13,Medicines Company (MDCO) Marked As A Barbarian At The Gate
2015-11-11,Alnylam Pharmaceuticals And The Medicines Company Announce That New ALN-PCSsc Results From Late-Breaking Presentation At American Heart Association Meeting Confirm Potential For Bi-Annual Hypercholesterolemia Dose Regimen
2015-11-04,The Medicines Company To Present New Data On Cardiovascular Portfolio At American Heart Association (AHA) Scientific Sessions
2015-11-03,Medicines Company (MDCO) Flagged As Strong On High Volume
2015-11-03,The Medicines Company Reports Third-Quarter And First Nine Months 2015 Business And Financial Results
2015-10-26,Results Of First-in-Man Study With Investigational Anesthetic ABP-700 Presented At ANESTHESIOLOGY® 2015 And International Society Of Anesthetic Pharmacology Annual Meetings
2015-10-22,The Medicines Company To Present Data On Potentially Innovative Surgical Anesthetic At American Society Of Anesthesiologists 2015 Meeting
2015-10-16,The Medicines Company To Announce Third Quarter 2015 Financial Results On Tuesday, November 3, 2015
2015-10-06,The Medicines Company And SymBio Pharmaceuticals Establish Strategic Partnership For IONSYS® (fentanyl Iontophoretic Transdermal System) In Japan
2015-10-01,The Medicines Company Announces Participation At IDWeek 2015 Meeting
2015-10-01,The Medicines Company Announces BARDA Exercises Next Option On Contract For Support Of The Development Of CARBAVANCE® (meropenem/RPX7009) For Drug-Resistant Gram-Negative Pathogens
2015-09-30,10 Best Nasdaq Biotech Stocks in the Third Quarter
2015-09-28,Short Interest Makes 17.2% Move For MDCO
2015-09-25,First Week Of November 20th Options Trading For Medicines
2015-09-25,The Medicines Company Receives CHMP Positive Opinion For IONSYS® To Treat Post-operative Pain In Adult Patients
2015-09-18,Trade-Ideas: Medicines Company (MDCO) Is Today's Post-Market Leader Stock
2015-09-18,The Medicines Company Reports Discovery Of New Series Of Beta-Lactamase Inhibitors At ICAAC/ICC 2015
2015-09-18,New Treatment Options For Carbapenem-Resistant Enterobacteriaceae (CRE) Infection Needed, According To Study By The Medicines Company
2015-09-15,The Medicines Company Announces Participation At ICAAC/ICC 2015 Meeting
2015-09-09,Medicines Company (MDCO) Hits New Lifetime High Today
2015-09-09,EUSA Pharma Appoints William W Crouse To Its Board Of Directors
2015-09-01,MATRIX Trial Results Presented At Hot Line Session Of ESC Congress 2015 And Simultaneously Published In The New England Journal Of Medicine
2015-09-01,Medicines Company (MDCO) Reaches New Lifetime High Today
2015-09-01,Analysis From CHAMPION PHOENIX Trial Highlight The Efficacy Of Cangrelor Among Patients Undergoing PCI Via The Radial Approach
2015-08-31,Market News: The Medicine Company, Netflix, Twitter
2015-08-31,3 High-Volume Stocks to Trade Now (or Not)
2015-08-31,3 Health Care Stocks Nudging The Sector Higher
2015-08-31,Medicines (MDCO) Stock Skyrockets Following Promising Cholesterol Drug Results
2015-08-31,Medicines Company (MDCO) Moving On Heavy Volume In The Pre-Market Hours
2015-08-31,The Medicines Company Appoints Dr. Fred Eshelman As Non-Executive Chairman Of The Board
2015-08-30,(Graphic: Business Wire)
2015-08-28,Analysts' Actions -- Akamai, Borg Warner, Urban Outfitters, United States Steel and More
2015-08-24,The Medicines Company Announces Participation At 2015 European Society Of Cardiology (ESC) Congress In London
2015-08-19,The Medicines Co. (MDCO) Stock Price Target Raised at Leerink
2015-07-29,Today's Weak On High Volume Stock: Medicines Company (MDCO)
2015-07-29,The Medicines Company Reports Second-Quarter And First-Half 2015 Financial Results
2015-07-13,The Medicines Company To Announce Second Quarter Financial Results On Wednesday July 29, 2015
2015-07-09,The Medicines Company Authorizes Generic Launch Of ANGIOMAX® (bivalirudin)
2015-07-07,4 Stocks Rising on Unusual Volume
2015-07-06,Strong On High Relative Volume: Medicines Company (MDCO)
2015-07-02,Will Medicines & Co. (MDCO) Stock be Hurt by Court Patent Ruling?
2015-07-02,Federal Circuit Rules Against The Medicines Company In Angiomax® (bivalirudin) Patent Litigation
2015-06-25,Medicines Company (MDCO) Marked As A Barbarian At The Gate
2015-06-22,KENGREAL(TM)(cangrelor)(Photo: Business Wire)
2015-06-11,Insider Trading Alert - CLCT, MDCO And LQ Traded By Insiders
2015-06-01,The Medicines Company To Hold Conference Call On Tuesday, June 2 To Discuss Clinical Trial Results Of ABP-700 And MDCO-216
2015-06-01,Bios/Backgrounders
2015-05-26,The Medicines Company Presents New Data Showing Remodeling Effect Of MDCO-216 On HDL Particles In Coronary Artery Disease Patients
2015-05-22,The Medicines Company To Participate In The Jefferies 2015 Healthcare Conference
2015-05-19,First Week Of January 2016 Options Trading For Medicines (MDCO)
2015-05-07,The Medicines Company To Participate In Bank Of America Merrill Lynch 2015 Health Care Conference
2015-05-05,The Medicines Company Reports First Quarter 2015 Financial Results And Operational Developments
2015-04-30,The Medicines Company Announces FDA Approval Of RAPLIXA™ (Fibrin Sealant), The First And Only Powdered Fibrin Sealant Ready-to-Use For Mild To Moderate Surgical Bleeding
2015-04-30,The Medicines Company Announces FDA Approval Of IONSYS® (fentanyl Iontophoretic Transdermal System) For The Management Of Acute Post-Operative Pain For Adult Patients In The Hospital
2015-04-21,Insider Trading Alert - AMP, MDCO And MEMP Traded By Insiders
2015-04-21,The Medicines Company To Announce First Quarter Financial Results On Tuesday, May 5, 2015
2015-04-20,Medicines Company (MDCO) Weak On High Volume
2015-04-20,FDA Approves New Formulation Of MINOCIN® (minocycline) For Injection
2015-04-15,FDA Advisory Committee Recommends Approval Of The Medicines Company's Antiplatelet Therapy Cangrelor
2015-04-15,The Medicines Company Stock Trading Halted Today
2015-04-13,Medicines Company (MDCO) Strong On High Relative Volume Today
2015-04-10,Medicines Company (MDCO) Moving On Heavy Volume In The Pre-Market Hours
2015-04-09,EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against The Medicines Company - MDCO
2015-04-09,The Medicines Company Announces Preliminary Worldwide Net Revenue For The First Quarter Of 2015
2015-04-01,The Medicines Company Settles Angiomax® (Bivalirudin) Patent Litigation With Sun
2015-03-30,The Medicines Company Receives European Commission Approval For Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV® (oritavancin) And RAPLIXA™ (sealant Powder)
2015-03-19,Insider Trading Alert - MDCO, NMIH And LNG Traded By Insiders
2015-03-16,Independent Research Confirms Reduction In Mortality And Bleeding Associated With Bivalirudin In High-Risk Acute Coronary Syndrome Patients Undergoing PCI
2015-03-11,The Medicines Company Announces Participation At 2015 American College Of Cardiology (ACC) Scientific Sessions In San Diego
2015-02-27,The Medicines Company To Participate In Cowen 35th Annual Health Care Conference
2015-02-20,The Medicines Company To Participate In 2015 RBC Capital Markets' Global Healthcare Conference
2015-02-18,The Medicines Company Reports Fourth Quarter And Full Year 2014 Financial Results
2015-02-12,Interesting MDCO Put And Call Options For March 20th
2015-02-12,Short Interest In Medicines Expands By 16.5%
2015-02-05,The Medicines Company To Participate In Leerink Global Healthcare Conference
2015-02-04,The Medicines Company Acquires Annovation Biopharma, Inc.
2015-02-04,The Medicines Company To Announce Fourth Quarter And Full Year 2014 Financial Results On Wednesday, February 18, 2015
2015-01-23,The Medicines Company Receives CHMP Positive Opinions For Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV™ (oritavancin) And RAPLIXA™ (sealant Powder)
2015-01-21,Eyes On Medicines Company (MDCO): Highlighted Storm The Castle Stock
2015-01-07,The Medicines Company Prices $350 Million Of Convertible Notes
2015-01-06,The Medicines Company Announces Intention To Offer $300 Million Of Convertible Notes
2015-01-05,The Medicines Company To Participate In 33rd Annual J.P. Morgan Healthcare Conference
2014-12-31,Weak On High Volume: Medicines Company (MDCO)
2014-12-24,Commit To Purchase Medicines At $21, Earn 11.9% Annualized Using Options
2014-12-18,The Medicines Company And SciClone Pharmaceuticals Establish Strategic Partnership For Two Cardiovascular Products In China
2014-12-11,Http://www.themedicinescompany.com/
2014-12-08,The Medicines Company To Participate In Oppenheimer 25th Annual Healthcare Conference
2014-11-16,The Medicines Company Presents New Phase 1 Data Showing Investigational Agent MDCO-216 Modified Key Lipid Parameters And Was Well-Tolerated In Healthy And Coronary Artery Disease (CAD) Patients
2014-11-14,The Medicines Company To Present New Data On Investigational Lipid-Modifying Agent MDCO-216 And Investigational Antiplatelet Agent Cangrelor At 2014 American Heart Association (AHA) Annual Scientific Sessions In Chicago
2014-11-11,The Medicines Company To Participate In Credit Suisse Healthcare Conference
2014-11-07,Health Economic Data On The Medicines Company's Infectious Disease And Cardiology Portfolios To Be Presented At The 17th Annual European Congress Of The International Society For Pharmacoeconomics And Outcomes Research (ISPOR)
2014-11-05,The Medicines Company Announces First Patient Enrollment In Phase 3 Studies Of CARBAVANCE™ In Development For The Treatment Of Serious Bacterial Infections Due To Gram-Negative Bacteria
2014-11-04,Update To The Medicines Company Investor & Analyst Day On November 5
2014-10-30,The Medicines Company To Webcast Investor & Analyst Day On November 5
2014-10-28,Twitter Takes A Tumble As Ability To Innovate Comes Into Question
2014-10-28,The Medicines Company Announces Presentation Of Investigational Hemostatic Agent RAPLIXA™ (fibrin Sealant) Phase III FINISH-3 Trial Results At The 2014 Clinical Conference Of The American College Of Surgeons
2014-10-28,Alnylam And The Medicines Company Announce Filing Of A Clinical Trial Application To Initiate A Phase 1 Study For ALN-PCSsc, An Investigational, Subcutaneously Administered RNAi Therapeutic Targeting PCSK9 For The Treatment Of Hypercholesterolemia
2014-10-27,The Medicines Company Wins Favorable Judgment In Angiomax® (Bivalirudin) Patent Litigation
